Yi Li, Ph.D., M.S.
Dr. Li is a biostatician with expertise in the application of high dimensional data to improve health outcomes. He serves as the Director of the Kidney Epidemiology Cost Center (UM-KECC), and he is involved developing metrics to evaluate the country’s dialysis centers, helping the Center for Medicare & Medicaid Services improve their policies for kidney patients, using big data to predict survival for kidney disease, assessing disparities in dialysis mortality outcomes, and also developing methods to analyze genomic associations with chronic diseases. He has also developed a collaboration with West China Hospital - the largest hospital in China - to help monitor and improve their kidney dialysis facilities. Dr. Li also leads a multidisciplinary group focused on the development of cutting-edge methods for big data arising from biomedical sciences.
- Ph.D., Biostatistics, University of Michigan
- M.S., Biostatistics, University of Michigan
- M.S., Mathematics, Tulane University
- B.S., Mathematics, Nanjing University
Health Services Research & Policy Focus
Collaborating Centers & Programs
What are you thinking about?
I am thinking of exploring all possible ways to acquire new knowledge to keep the quality of our research at UM-KECC at the highest level. Retaining UM-KECC's traditionally strong position in end-stage renal disease (ESRD), I also have been thinking about significantly expanding our research to include other chronic diseases.
What are the practical implications for healthcare?
Our research at UM-KECC has addressed the efficiency of care delivery at the individual and population levels in order to support value-based purchasing initiatives. In addition, our work has provided the evidence-based results for health care policymakers, and has made scientific advances in health outcomes research, clinical medicine, public health and health care delivery.
Why is this interesting to you?
It is a great honor to lead UM-KECC, which features a combined force of world-class investigators from the School of Public Health and the Medical School. Our work has an impact on improving quality and efficiency of care delivered to both government program (e.g. Medicare and Medicaid) beneficiaries and the general U.S. population.